cbdMD, Inc. (YCBD)
0.3798
+0.02
(+4.11%)
USD |
NYAM |
Oct 27, 16:00
0.3798
0.00 (0.00%)
After-Hours: 17:18
cbdMD Cash from Operations (Quarterly) : -0.4422M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4422M |
| March 31, 2026 | -0.7225M |
| December 31, 2025 | -0.8125M |
| September 30, 2025 | -0.2407M |
| June 30, 2025 | -0.7042M |
| March 31, 2025 | -0.1895M |
| December 31, 2024 | -0.3179M |
| September 30, 2024 | 0.0979M |
| June 30, 2024 | 0.2898M |
| March 31, 2024 | -0.7041M |
| December 31, 2023 | -0.1124M |
| September 30, 2023 | -0.2635M |
| June 30, 2023 | -0.2406M |
| March 31, 2023 | -1.734M |
| December 31, 2022 | -2.170M |
| September 30, 2022 | -1.926M |
| June 30, 2022 | -2.265M |
| March 31, 2022 | -5.471M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.590M |
| September 30, 2021 | -4.334M |
| June 30, 2021 | -4.868M |
| March 31, 2021 | -2.936M |
| December 31, 2020 | -2.216M |
| September 30, 2020 | 0.5938M |
| June 30, 2020 | -0.9979M |
| March 31, 2020 | -4.203M |
| December 31, 2019 | -5.119M |
| September 30, 2019 | -4.859M |
| June 30, 2019 | -4.854M |
| March 31, 2019 | -3.874M |
| December 31, 2018 | -1.029M |
| September 30, 2018 | -1.405M |
| June 30, 2018 | -1.288M |
| March 31, 2018 | -1.462M |
| December 31, 2017 | -2.091M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tilray Brands, Inc. | -16.54M |
| Organogenesis Holdings, Inc. | -31.65M |
| Guardian Pharmacy Services, Inc. | 30.02M |
| Elite Pharmaceuticals, Inc. | 10.07M |
| Daré Bioscience, Inc. | -6.775M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0181M |
| Cash from Financing (Quarterly) | -0.0597M |
| Free Cash Flow | -2.409M |
| Free Cash Flow Per Share (Quarterly) | -0.0434 |
| Free Cash Flow to Equity (Quarterly) | -2.258M |
| Free Cash Flow to Firm (Quarterly) | -0.4603M |
| Free Cash Flow Yield | -65.09% |